Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.30 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1475983 | 0.91 | — | — | |
| SCHEMBL12146535 | 0.86 | TSHR (0.30) | — | |
| SCHEMBL12304992 | 0.86 | ALDH1A1 (0.31) | ALDH1A1 | |
| Ether SCHEMBL1476217 | 0.84 | ALDH1A1 (0.40) | ALDH1A1CYP4F2CYP4A11 | |
| SCHEMBL25565567 | 0.84 | — | — | |
| SCHEMBL13455172 | 0.83 | — | — | |
| SCHEMBL20616543 | 0.83 | — | — | |
| SCHEMBL25565508 | 0.82 | — | — | |
| SCHEMBL12819577 | 0.82 | CYP4F2 (0.33) | CYP4F2CYP4A11 | |
| SCHEMBL369442 | 0.82 | ALDH1A1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3924326-B1 | METHOD FOR OBTAINING OLEACEIN AND OLEOMISSIONAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS | Omphax SA (GR) | 2023-06-07 | — | — | EP | disclosed |
| US-20220119335-A1 | METHOD FOR OBTAINING OLEACEIN AND OLEOMISSIONAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS | Omphax SA (GR) | 2022-04-21 | — | — | US | disclosed |
| EP-3715949-A1 | COMPOSITION FOR FORMING FILM FOR LITHOGRAPHY, FILM FOR LITHOGRAPHY, RESIST PATTERN FORMING METHOD, AND CIRCUIT PATTERN FORMING METHOD | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-09-30 | — | — | EP | disclosed |
| WO-2020165613-A1 | METHOD FOR OBTAINING OLEACEIN AND OLEOMISSIONAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS | MAGIATIS PROKOPIOS (GR) | 2020-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119335-A1 | METHOD FOR OBTAINING OLEACEIN AND OLEOMISSIONAL TYPE SECOIRIDOIDS AND FOR PRODUCING RESPECTIVE PHARMACEUTICAL PREPARATIONS | PNLIP, PCSK9, ALOX12 | ALDH1A1 1879/4885CYP4F2 3266/4885CYP4A11 980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.